Capricor therapeutics, inc. (CAPR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
REVENUE
Collaboration income

-

-

-

-

-

-

-

-

-

-

0

683

683

683

683

911

911

911

911

911

1,041

1,041

1,041

1,041

1,041

0

0

0

0

-

0

0

195

-

813

346

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

185

222

142

410

230

648

219

403

400

-

-

312

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

52

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

197

223

63

218

303

211

403

380

746

360

259

0

0

0

80

189

233

1,898

0

0

0

-

0

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL REVENUE

185

-

-

-

230

-

-

-

-

475

313

996

880

906

746

1,129

1,215

1,123

1,314

1,291

1,787

1,401

1,301

1,041

1,041

0

80

189

233

-

0

0

195

-

813

346

-

-

-

OPERATING EXPENSES
Research and development

1,155

828

857

1,644

1,811

2,849

3,131

3,388

2,696

2,518

1,862

3,128

3,257

2,665

4,727

4,307

4,341

3,330

3,192

3,426

3,807

2,589

1,966

1,856

1,374

1,683

1,010

1,311

1,191

1,657

179

332

465

1,341

1,470

702

622

1,148

1,055

General and administrative

1,138

876

911

831

976

1,104

1,259

1,178

1,389

1,237

1,088

1,246

1,189

1,154

1,259

1,434

1,084

1,077

972

926

1,395

679

819

665

852

677

563

492

474

25

397

441

500

518

499

523

575

664

445

TOTAL OPERATING EXPENSES

2,293

1,705

1,769

2,476

2,787

3,954

4,391

4,566

4,086

3,756

2,951

4,375

4,446

3,820

5,986

5,742

5,425

4,408

4,165

4,353

5,202

3,268

2,786

2,522

2,227

2,361

1,574

1,804

1,665

1,682

576

774

965

1,860

1,969

1,226

1,197

1,812

1,501

LOSS FROM OPERATIONS

-2,107

-1,483

-1,627

-2,065

-2,557

-3,305

-4,171

-4,163

-3,686

-3,280

-2,637

-3,378

-3,565

-2,913

-5,240

-4,612

-4,210

-3,284

-2,850

-3,061

-3,414

-1,867

-1,485

-1,480

-1,185

-2,361

-1,494

-1,615

-1,432

20

-576

-774

-769

-1,664

-1,156

-880

-1,197

-1,812

-1,501

OTHER INCOME (EXPENSE)
Investment income

22

13

21

21

37

46

35

39

14

11

10

12

4

-1

5

0

10

2

0

0

0

-0

1

1

0

0

-27

-3

18

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed asset

-

-

0

-2

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

1

1

1

5

6

Interest expense

-

-

-

-

-

-

-

-

-

80

107

105

105

102

98

76

66

63

61

61

61

60

60

54

25

24

23

6

3

0

0

0

0

-

0

-

-

-

-

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

420

-2

-0

10

-1

-0

-2

-0

TOTAL OTHER INCOME (EXPENSE)

22

-

-

-

37

-

-

-

-

15,585

-97

-93

-101

-1,604

-93

-76

-55

-61

-61

-61

-61

-61

-58

-53

-25

-1,943

-51

-9

15

-400

10

421

-2

0

12

-0

1

3

6

NET LOSS

-2,084

-1,469

-1,606

-2,046

-2,519

-3,259

-4,136

-4,123

-3,671

12,305

-2,734

-3,472

-3,666

-4,518

-5,333

-4,688

-4,266

-3,346

-2,911

-3,123

-3,476

-1,928

-1,543

-1,533

-1,210

-4,304

-1,545

-1,624

-1,417

-380

-566

-352

-771

-1,664

-1,144

-880

-1,195

-1,809

-1,494

OTHER COMPREHENSIVE INCOME (LOSS)
Net unrealized gain (loss) on marketable securities

0

-0

0

0

-12

-7

1

-2

8

3

1

-2

6

2

-3

1

-6

-2

5

10

-3

1

-0

-0

0

1

30

-2

-8

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS

-2,100

-1,554

-1,600

-2,000

-2,500

-3,327

-4,100

-4,100

-3,662

12,308

-2,733

-3,474

-3,660

-4,515

-5,337

-4,687

-4,272

-3,348

-2,906

-3,112

-3,480

-1,926

-1,544

-1,534

-1,210

-

-1,515

-1,627

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,425

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted

-0.30

-0.29

-0.43

-0.59

-0.75

-2.26

-1.35

-1.42

-0.14

0.55

-0.12

-0.16

-0.17

-

-0.29

-0.26

-0.26

-0.21

-0.18

-0.19

-0.23

-0.17

-0.13

-0.13

-0.10

-0.40

-0.15

-0.16

-0.14

-0.17

-0.01

-0.01

-0.02

-0.04

-0.03

-0.03

-0.03

-0.05

-0.05

Weighted average number of shares, basic and diluted

6,878

4,293

3,746

3,457

3,347

-21,105

3,060

2,903

26,905

25,860

23,378

22,135

21,399

-

18,286

17,952

16,537

16,273

16,242

16,222

14,869

11,706

11,700

11,692

11,689

10,951

10,351

10,351

10,351

-85,945

43,062

42,951

39,712

-

39,707

35,091

-

-

-

Weighted-average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,673

34,563

32,285